Status:
COMPLETED
Omentin-1 Level in Psoriatic Patients Treated With Narrowband Ultraviolet B Phototherapy Versus Acitretin
Lead Sponsor:
Mahmoud Ahmed Ali Ahmed
Conditions:
Psoriasis
Eligibility:
All Genders
20-50 years
Phase:
PHASE4
Brief Summary
Studying the effects of Narrowband Ultraviolet B versus acitretin on psoriatic patients
Detailed Description
Compare the effects of Narrowband Ultraviolet B versus acitretin on serum Omentin-1 level in psoriatic patients as case control study by dividing patients into 3 groups: group 1 include patients recei...
Eligibility Criteria
Inclusion
- Patients of both sexes with psoriasis vulgaris.
Exclusion
- • Patients with history of malignancies, renal and liver diseases.
- Patients received NB-UVB phototherapy in the last 6 months.
- Patients treated with methotrexate or biologic agents and any systemic treatment of psoriasis.
Key Trial Info
Start Date :
September 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 15 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05203354
Start Date
September 1 2018
End Date
August 15 2021
Last Update
January 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of medicine - Aswan university
Aswān, Egypt, 81528